Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Teva Neuroscience, Inc. et al v. Apotex Inc. et al
Case Number:
0:11-cv-61402
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
August 26, 2011
Teva Nixes Suit Against Apotex Over Parkinson's Drug
Teva Pharmaceuticals agreed to drop its patent infringement claims against Apotex Corp. in Florida federal court on Thursday, ending the short-lived battle over a generic version of Parkinson's disease drug Azilect.
-
June 23, 2011
Teva Targets Apotex Over Generic Parkinson's Drug
Teva Pharmaceutical Industries Ltd. sued Apotex Corp. for patent infringement in Florida on Wednesday over its efforts to make a generic version of Parkinson's disease treatment Azilect.